33 results
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
effects of COVID-19 on patients;
diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving … not achieve adequate market acceptance by physicians, patients, healthcare payors, and others in the medical community necessary for commercial
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
4.18
Transactions with Affiliates
Section 4.19
Healthcare Regulatory Matters
Section 4.20
FDA
Section 4.21
Trade Laws
Section 4.22
Brokers
Section … that would be or will be required to be disclosed pursuant to Item 404(a) of Regulation S-K of the SEC.
Section 4.19 Healthcare Regulatory Matters
8-K
EX-2.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
Taxes
Section 4.16
Insurance
Section 4.17
Labor Matters
Section 4.18
Transactions with Affiliates
Section 4.19
Healthcare Regulatory Matters
Section … S-K of the SEC.
Section 4.19 Healthcare Regulatory Matters.
(a) Each of Parent and its Subsidiaries and, to the Knowledge of Parent
8-K
8ajwe9j0xqf
18 May 22
Applied Molecular Transport Provides Strategy Update
8:18am
8-K
EX-1.1
39tw gao0zb47v9au90g
28 Jan 22
Entry into a Material Definitive Agreement
12:00am
DEF 14A
d6j7ikrb64bi2 35
7 Apr 21
Definitive proxy
4:05pm
424B4
rpt89y3
1 Apr 21
Prospectus supplement with pricing info
4:05pm